Outset Medical (OM) Short term Debt (2019 - 2022)
Outset Medical's (OM) quarterly Short term Debt came in at $1.0 million in Q2 2022, down 86.67% on a QoQ basis from $7.5 million in Q4 2019.
Outset Medical (OM) Short term Debt (2019 - 2022) Analysis & Trends
Outset Medical (OM) has 2 years of Short term Debt data on file, last reported at $1.0 million in Q2 2022.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $1.0 million in Q2 2022; TTM through Jun 2022 was $1.0 million, a N/A change from a year earlier, with the FY2019 full-year figure at $7.5 million, changed N/A from the prior year.
- Short term Debt for Q2 2022 stood at $1.0 million, down from $7.5 million in the prior quarter.
- Over the last five years, Short term Debt for OM reached as high as $7.5 million in Q4 2019 and fell as low as $1.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Outset Medical | 78,728.30 | -286.57 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.00 Mn |
| Dec 31, 2019 | 7.50 Mn |